Indeed, Cdc20 upregulation has been demonstrated in several types of cancers, including breast and colon cancer, and it contributes to aggressive tumor progression and poor prognosis in gastric cancer and primary non-small cell lung cancer (Chi et al., 2019). The gene discussed is CDC20; the disease is gastric cancer.